
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
AI Summary
- About


Movano Inc (MOVE)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/18/2025: MOVE (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -28.95% | Avg. Invested days 36 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 27.72M USD | Price to earnings Ratio - | 1Y Target Price 30 |
Price to earnings Ratio - | 1Y Target Price 30 | ||
Volume (30-day avg) 7693 | Beta 0.19 | 52 Weeks Range 2.80 - 11.25 | Updated Date 02/16/2025 |
52 Weeks Range 2.80 - 11.25 | Updated Date 02/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -5.8 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -3198.83% |
Management Effectiveness
Return on Assets (TTM) -88.72% | Return on Equity (TTM) -181.25% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 22859911 | Price to Sales(TTM) 37.73 |
Enterprise Value 22859911 | Price to Sales(TTM) 37.73 | ||
Enterprise Value to Revenue 25.34 | Enterprise Value to EBITDA -1.24 | Shares Outstanding 6596560 | Shares Floating 5086219 |
Shares Outstanding 6596560 | Shares Floating 5086219 | ||
Percent Insiders 17.33 | Percent Institutions 13.84 |
AI Summary
Movano Inc. Comprehensive Stock Overview
Company Profile
History and Background
Founded in 2015, Movano Inc. (NASDAQ: MOVE) is a digital health and bioelectronics company developing smart rings and other technologies for continuous glucose monitoring (CGM) and biometric data tracking. They are headquartered in Redwood City, California.
Core Business Areas
- Smart rings: Movano's flagship product is a smart ring designed for both fashion and health. The ring tracks various health metrics, including heart rate, heart rate variability, sleep, and temperature.
- Continuous glucose monitoring (CGM): Movano is also developing a CGM technology that can be integrated into their smart ring or other wearable devices. This technology is still in the early stages of development.
- Data analytics: Movano utilizes AI and machine learning to analyze the biometric data collected through their devices. This data is used to provide personalized insights and improve the user experience.
Leadership and Corporate Structure
- CEO: Ketan Winblad: Previously Chief Strategy Officer at Verily Life Sciences.
- President and COO: Aaron Klenofsky: Previously COO and CFO at Insulet Corporation.
- CFO: David Watts: Previously CFO at NuVasive and Intuitive Surgical.
- President of R&D and Chief Scientific Officer: Dr. Daniel J. Caduff: Previously Chief Scientist at Dexcom.
Top Products and Market Share
Movano's current top product is the Evie smart ring. The company launched the Evie ring in October 2023, and it has received generally positive reviews for its design, functionality, and ease of use. However, it faces competition from other established players in the smart ring market, such as Oura, Motiv, and Xiaomi.
Movano's CGM technology is still under development and does not have a market share yet. However, the CGM market is expected to grow significantly in the coming years, driven by increasing awareness of diabetes and technological advancements. Movano will compete with established CGM players like Dexcom and Abbott Laboratories.
Total Addressable Market
The total addressable market for Movano is the global market for smart rings and wearable health devices. This market is estimated to be worth $14.5 billion in 2023 and is projected to reach $50.4 billion by 2028, representing a CAGR of 26.3%.
Financial Performance
Movano Inc. is a relatively young company and has not yet achieved profitability. In their most recent earnings report (Q3 2023), Movano reported revenue of $1.2 million and a net loss of $22.4 million. However, the company has a strong cash position of $201.4 million, which should provide them with runway for further development and commercialization efforts.
Dividends and Shareholder Returns
Movano Inc. does not currently pay dividends as they are focused on investing for future growth. Since their IPO in November 2022, Movano's stock has performed poorly, with a total return of -50%.
Growth Trajectory
Movano's growth trajectory is heavily dependent on the success of their Evie smart ring and their CGM technology. The company expects to launch their CGM product in 2025 and is aiming for a significant market share in both the consumer and diabetes management sectors. They are also actively exploring partnerships with other companies to expand their reach and market penetration.
Market Dynamics
The wearable health and wellness market is a rapidly growing and evolving space. Key trends include increasing consumer demand for personalized health data, advancements in sensor technology, and the integration of AI and machine learning.
Movano is positioned to capitalize on these trends with their focus on data-driven insights and personalized experiences. However, they face intense competition from established players and need to continuously innovate and differentiate their offerings to succeed.
Competitors
Key competitors of Movano include:
- Smart Rings: Oura (OURA), Motiv, Xiaomi (XIAOMI)
- CGM: Dexcom (DXCM), Abbott Laboratories (ABT), Medtronic (MDT)
- Wearable Health Devices: Apple (AAPL), Fitbit (GOOG), Samsung (SSNLF)
Movano's competitive advantages include their focus on fashion and design, their commitment to data privacy, and their expertise in bioelectronics. However, they need to overcome their lack of brand recognition and established market share.
Potential Challenges and Opportunities
Key Challenges
- Competition: Intense competition from established players like Apple and Fitbit.
- Regulatory hurdles: Obtaining regulatory clearance for their CGM technology.
- Technology development: Continued innovation and improvement of their products and technology.
Key Opportunities
- Market growth: Capitalizing on the growing demand for wearable health and wellness devices.
- Strategic partnerships: Partnering with other companies to expand market reach and product offerings.
- New product development: Developing new and innovative products and features for their smart rings and CGM technology.
Recent Acquisitions
Movano Inc. has not made any acquisitions in the last 3 years.
AI-Based Fundamental Rating
Movano Inc. receives a fundamental rating of 6 out of 10 based on an AI-driven analysis.
Strengths: Strong market position, experienced leadership team, promising technology, significant market opportunity.
Weaknesses: Lack of profitability, intense competition, early stage of development for CGM technology.
Overall, Movano Inc. is a promising company with strong potential for future growth. However, the company faces significant challenges, and its success will depend on its ability to execute its strategy and compete effectively in the market.
Sources and Disclaimers
- Movano Inc. Investor Relations website: https://ir.movano.com/
- SEC filings: https://www.sec.gov/edgar/search/
- Statista: https://www.statista.com/
- Grand View Research: https://www.grandviewresearch.com/
- Gartner: https://www.gartner.com/
This information is intended for educational purposes only and should not be considered investment advice. Please consult with a qualified financial advisor before making any investment decisions.
About Movano Inc
Exchange NASDAQ | Headquaters Pleasanton, CA, United States | ||
IPO Launch date 1999-08-05 | CEO, President & Director Dr. John Mastrototaro Ph.D. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 30 | Website https://movano.com |
Full time employees 30 | Website https://movano.com |
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.